NASDAQ: LABStandard Biotools Inc Stock Ownership - Who owns Standard Biotools?
Insider buying vs selling
Have Standard Biotools Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Michael Egholm | President CEO | 2026-04-06 | 95,014 | $0.91 | $86.27kSell |
| Hanjoon Alex Kim | Chief Financial Officer | 2026-04-06 | 21,301 | $0.91 | $19.34kSell |
| Thomas D. Carey | Director | 2026-02-26 | 51,282 | $1.17 | $60.00kBuy |
| Troy Cox | Director | 2026-02-26 | 57,264 | $1.17 | $67.00kBuy |
| Eli Casdin | Director | 2026-02-26 | 52,991 | $1.17 | $62.00kBuy |
| Hanjoon Alex Kim | Chief Financial Officer | 2026-02-23 | 12,740 | $1.15 | $14.65kSell |
| Sean MacKay | SVP Chief Business Officer | 2026-02-23 | 19,661 | $1.15 | $22.61kSell |
| Michael Egholm | President CEO | 2026-02-23 | 66,127 | $1.15 | $76.05kSell |
| Casdin Partners Master Fund LP | Director | 2025-12-04 | 150,000 | $1.45 | $217.05kBuy |
| Casdin Partners Master Fund LP | Director | 2025-12-03 | 75,000 | $1.44 | $108.00kBuy |
LAB insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when LAB insiders and whales buy or sell their stock.
LAB Shareholders
What type of owners hold Standard Biotools Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Eli Casdin | 46.59% | 181,734,609 | $169.01M | Insider |
| Casdin Capital LLC | 22.76% | 88,783,856 | $82.57M | Institution |
| Casdin Partners Master Fund LP | 18.84% | 73,487,321 | $68.34M | Insider |
| Viking Global Investors LP | 15.04% | 58,651,170 | $54.55M | Institution |
| Blackrock Inc | 6.54% | 25,515,933 | $23.73M | Institution |
| Viking Global Investors LP | 4.96% | 19,354,860 | $18.00M | Insider |
| Mak Capital One LLC | 4.94% | 19,288,158 | $17.94M | Institution |
| Vanguard Group Inc | 4.43% | 17,297,599 | $16.09M | Institution |
| Long Focus Capital Management LLC | 3.25% | 12,678,403 | $11.79M | Institution |
| Caligan Partners LP | 2.00% | 7,797,454 | $7.25M | Insider |
LAB vs Diagnostic & Research Stocks
Standard Biotools Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.